1. A phase I clinical trial demonstrates that nfP2X7‐targeted antibodies provide a novel, safe and tolerable topical therapy for basal cell carcinoma. (11th June 2017) Authors: Gilbert, S.M.; Gidley Baird, A.; Glazer, S.; Barden, J.A.; Glazer, A.; Teh, L.C.; King, J. Journal: British journal of dermatology Issue: Volume 177:Number 1(2017) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase I clinical trial demonstrates that nfP2X7‐targeted antibodies provide a novel, safe and tolerable topical therapy for basal cell carcinoma. (1st July 2017) Authors: Gilbert, S.M.; Gidley Baird, A.; Glazer, S.; Barden, J.A.; Glazer, A.; Teh, L.C.; King, J. Journal: British journal of dermatology Issue: Volume 177:Number 1(2017) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The Kyrenia Terrane (Northern Cyprus): Detrital Zircon Evidence for Exotic Elements in the Southern Neotethys. Issue 10 (19th October 2021) Authors: Glazer, A.; Avigad, D.; Morag, N.; Güngör, T.; Gerdes, A. Journal: Tectonics Issue: Volume 40:Issue 10(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗